The CT-388 study was a 24 week study so I would think an effect from GI tolerability would be lessened although it could have had a very small impact. Just no way of telling in any case because Roche RHHBY didn't release any detailed tolerability data.
"People are best convinced by reasons they discover themselves"
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.